| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Thursday’s Close |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | $432.64 | $46.36B | Uptrend |
Wall Street Breakfast: U.S. Jobs Report - A Familiar Story?
https://seekingalpha.com/article/4194309-wall-street-breakfast-u-s-jobs-report-familiar-story?source=feed_tag_wall_st_breakfast
Aug 03, 2018 -
0
Company News For Aug 3, 2018
http://www.zacks.com/stock/news/315793/company-news-for-aug-3-2018?cid=CS-ZC--315793
Aug 03, 2018 - Companies in the news are:
CI, TSLA, TEVA and REGN
0
Applied Genetic Technologies Corporation: Near-Term Run Up Expected
https://seekingalpha.com/article/4189316-applied-genetic-technologies-corporation-near-term-run-expected?source=feed_sector_healthcare
Jul 23, 2018 - Shares are trading at roughly a third of the original IPO price. Recent accumulation is indicative of further upside in the near term. Pessimism and past setbacks have led to an incredibly cheap valua
0
Intellia Therapeutics: Left Behind The Cas9 Excitement
https://seekingalpha.com/article/4188960-intellia-therapeutics-left-behind-cas9-excitement?source=feed_sector_healthcare
Jul 22, 2018 - NTLA is working to develop lipid nanoparticles for CRISPR delivery - a unique advantage. The company continues to progress, and has a strong cash reserve for the upcoming years. Without a Phase I tria
0
Allergan's Big Win For 12-Week Wet AMD Dosing With Abicipar May Be Enough To Pit It Against A Host Of Competitors
https://seekingalpha.com/article/4188613-allergans-big-win-12-week-wet-amd-dosing-abicipar-may-enough-pit-host-competitors?source=feed_sector_healthcare
Jul 20, 2018 - Allergan and Molecular Partners achieve positive results in two phase 3 studies using abicipar for treating patients with wet age-related macular degeneration.The primary endpoints for both phase 3 st
0
Pfizer & Lilly's Pain Candidate Succeeds in Phase III Study
http://www.zacks.com/stock/news/312287/pfizer-lillys-pain-candidate-succeeds-in-phase-iii-study?cid=CS-ZC-FT-312287
Jul 19, 2018 - Pfizer (PFE) and Eli Lilly (LLY) announce that their investigational pain candidate, tanezumab, significantly reduces pain in osteoarthritis patients.
0
Cheap Stocks Moving In The Right Direction
https://seekingalpha.com/article/4188010-cheap-stocks-moving-right-direction?source=feed_all_articles
Jul 18, 2018 - What can be better than buying a cheap stock? Buying a cheap stock that is moving in the right direction.Introducing a quantitative system focused on companies with low PEG ratio and rising earnings e
1
Playing The Expectations Game In Biotech
https://seekingalpha.com/article/4187892-playing-expectations-game-biotech?source=feed_all_articles
Jul 17, 2018 - The biotechnology sector is fertile ground for highly profitable investments, but the downside risk in the sector is also above average.Since the dispersion in returns is so wide, picking the right in
1
Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug
https://seekingalpha.com/article/4187810-gileads-hiv-franchise-assault-stares-paradigm-changing-drug?source=feed_sector_healthcare
Jul 17, 2018 - Patent fight with Glaxo dampens Biktarvy sales.HIV franchise losing dominance to new entrants.Empty HIV pipeline could lead to acquisitions.PRO 140 represents paradigm changing drug.CytoDyn acquisitio
4
Allergan: Crucial Period Ahead For Company As Activist Pressure Mounts
https://seekingalpha.com/article/4187408-allergan-crucial-period-ahead-company-activist-pressure-mounts?source=feed_sector_healthcare
Jul 16, 2018 - Allergan is under pressure from activist shareholders and other investors to formulate a clear strategic plan and make more drastic changes to the company.Botox Aesthetics, Botox Migraine, and Restasi
0
Page 1>
Related Companies
| Name | Exchange | Price | Mkt Cap | |
| SHPG | Shire plc | NASDAQ | $155.08 | $46.95B |
| VRTX | Vertex Pharmaceuticals Incorporated | NASDAQ | $151.24 | $38.13B |
| ALXN | Alexion Pharmaceuticals, Inc. | NASDAQ | $142.85 | $31.88B |
| ZTS | Zoetis Inc. | NYSE | $64.16 | $31.38B |
| AGN | Allergan plc. | NYSE | $204.65 | $68.42B |